TELA Bio, Inc. (TELA) stock
TELANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.78+0.02 (+2.36%)
Close on Nov 18, 2026Market cap $35.02MP/E –Yield –
TELA Bio price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
TELA Bio's price to sales ratio was 0.5× on Nov 11, 2026, against 0.6× a year earlier. Over the last 5 years it ranged from 0.3× to 6.9×, with a median of 1.9×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.5× | −0.1 |
| 2025 | Dec 31, 2025 | 0.6× | −0.5 |
| 2024 | Dec 31, 2024 | 1.1× | −2.0 |
| 2023 | Dec 29, 2023 | 3.1× | −2.7 |
| 2022 | Dec 30, 2022 | 5.8× | −1.2 |
| 2021 | Dec 31, 2021 | 6.9× | −7.1 |
| 2020 | Dec 31, 2020 | 14.1× | +13.7 |
| 2019 | Dec 31, 2019 | 0.3× | – |
See a number that looks wrong?